Liu J, Qu J, Xu L, Qiao C, Shao G, Liu X
Front Immunol. 2023; 14:1147797.
PMID: 37180166
PMC: 10174299.
DOI: 10.3389/fimmu.2023.1147797.
Zhang Z, Liu D, Hao D, Zhou Z
Front Surg. 2022; 9:833373.
PMID: 35372475
PMC: 8972198.
DOI: 10.3389/fsurg.2022.833373.
Nassour I, Christie A, Choti M, Mansour J, Minter R, Polanco P
J Gastrointest Surg. 2018; 22(5):792-801.
PMID: 29546687
DOI: 10.1007/s11605-018-3737-6.
Best L, Rawji V, Pereira S, Davidson B, Gurusamy K
Cochrane Database Syst Rev. 2017; 4:CD010213.
PMID: 28415140
PMC: 6478242.
DOI: 10.1002/14651858.CD010213.pub2.
Gudjonsson B
HPB Surg. 2016; 2016:6839687.
PMID: 27847403
PMC: 5099466.
DOI: 10.1155/2016/6839687.
Where does chemotherapy stands in the treatment of ampullary carcinoma? A review of literature.
Ghosn M, Kourie H, El Rassy E, Haddad F, Hanna C, El Karak F
World J Gastrointest Oncol. 2016; 8(10):745-750.
PMID: 27795814
PMC: 5064052.
DOI: 10.4251/wjgo.v8.i10.745.
Diagnostic accuracy of different imaging modalities following computed tomography (CT) scanning for assessing the resectability with curative intent in pancreatic and periampullary cancer.
Tamburrino D, Riviere D, Yaghoobi M, Davidson B, Gurusamy K
Cochrane Database Syst Rev. 2016; 9:CD011515.
PMID: 27631326
PMC: 6457597.
DOI: 10.1002/14651858.CD011515.pub2.
Diagnostic accuracy of laparoscopy following computed tomography (CT) scanning for assessing the resectability with curative intent in pancreatic and periampullary cancer.
Allen V, Gurusamy K, Takwoingi Y, Kalia A, Davidson B
Cochrane Database Syst Rev. 2016; 7:CD009323.
PMID: 27383694
PMC: 6458011.
DOI: 10.1002/14651858.CD009323.pub3.
Pancreas-sparing duodenectomy with regional lymph node dissection for early-stage ampullary carcinoma: A case control study using propensity scoring methods.
Liu B, Li J, Zhang Y, Yan L, You S, Lau W
World J Gastroenterol. 2015; 21(18):5488-95.
PMID: 25987771
PMC: 4427670.
DOI: 10.3748/wjg.v21.i18.5488.
Long-term survival after resection for non-pancreatic periampullary cancer followed by adjuvant intra-arterial chemotherapy and concomitant radiotherapy.
Erdmann J, Morak M, Duivenvoorden H, van Dekken H, Kazemier G, Kok N
HPB (Oxford). 2015; 17(7):573-9.
PMID: 25800041
PMC: 4474503.
DOI: 10.1111/hpb.12401.
Is local resection adequate for T1 stage ampullary cancer?.
Amini A, Miura J, Jayakrishnan T, Johnston F, Tsai S, Christians K
HPB (Oxford). 2014; 17(1):66-71.
PMID: 25395092
PMC: 4266442.
DOI: 10.1111/hpb.12297.
Defining the role of adjuvant external beam radiotherapy on resected adenocarcinoma of the ampulla of vater.
Miura J, Jayakrishnan T, Amini A, Johnston F, Tsai S, Erickson B
J Gastrointest Surg. 2014; 18(11):2003-8.
PMID: 25159502
DOI: 10.1007/s11605-014-2629-7.
The expression of PTEN is associated with improved prognosis in patients with ampullary adenocarcinoma after pancreaticoduodenectomy.
Shroff S, Overman M, Rashid A, Shroff R, Wang H, Chatterjee D
Arch Pathol Lab Med. 2013; 137(11):1619-26.
PMID: 24168499
PMC: 4640926.
DOI: 10.5858/arpa.2012-0418-OA.
Impact of Standardized Allergen-Removed Rhus verniciflua Stokes Extract on Advanced Adenocarcinoma of the Ampulla of Vater: A Case Series.
Choi W, An S, Kwon E, Eo W, Lee S
Evid Based Complement Alternat Med. 2013; 2013:203168.
PMID: 23710214
PMC: 3654714.
DOI: 10.1155/2013/203168.
Evaluation of adjuvant chemoradiation therapy for ampullary adenocarcinoma: the Johns Hopkins Hospital-Mayo Clinic collaborative study.
Narang A, Miller R, Hsu C, Bhatia S, Pawlik T, Laheru D
Radiat Oncol. 2011; 6:126.
PMID: 21951377
PMC: 3204241.
DOI: 10.1186/1748-717X-6-126.
Lymph node involvement and not the histophatologic subtype is correlated with outcome after resection of adenocarcinoma of the ampulla of vater.
Haddad L, Patzina R, Penteado S, Montagnini A, da Cunha J, Machado M
J Gastrointest Surg. 2010; 14(4):719-28.
PMID: 20107918
DOI: 10.1007/s11605-010-1156-4.
The efficacy of frontline platinum-based combination chemotherapy in advanced adenocarcinoma of the ampulla of Vater.
Kim S, Lee J, Lee K, Lee J, Lee K, Choi S
Med Oncol. 2009; 27(4):1149-54.
PMID: 19898973
DOI: 10.1007/s12032-009-9351-4.
Pancreatobiliary versus intestinal histologic type of differentiation is an independent prognostic factor in resected periampullary adenocarcinoma.
Westgaard A, Tafjord S, Farstad I, Cvancarova M, Eide T, Mathisen O
BMC Cancer. 2008; 8:170.
PMID: 18547417
PMC: 2430209.
DOI: 10.1186/1471-2407-8-170.
Prognostic impact of perineural invasion following pancreatoduodenectomy with lymphadenectomy for ampullary carcinoma.
Sudo T, Murakami Y, Uemura K, Hayashidani Y, Hashimoto Y, Ohge H
Dig Dis Sci. 2007; 53(8):2281-6.
PMID: 18095164
DOI: 10.1007/s10620-007-0117-6.
Occult tumor cells in lymph nodes as a predictor for tumor relapse in pancreatic adenocarcinoma.
Scheunemann P, Stoecklein N, Rehders A, Bidde M, Metz S, Peiper M
Langenbecks Arch Surg. 2007; 393(3):359-65.
PMID: 17704938
DOI: 10.1007/s00423-007-0215-0.